ContractClinical Manufacturing and Supply Agreement • May 14th, 2021 • Roivant Sciences Ltd. • Delaware
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE DERMAVANT SCIENCES LTD. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO DERMAVANT SCIENCES LTD. IF PUBLICLY DISCLOSED.
ContractClinical Manufacturing and Supply Agreement • March 11th, 2019 • Dermavant Sciences LTD • Pharmaceutical preparations • Delaware
[***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
CLINICAL MANUFACTURING AND SUPPLY AGREEMENTClinical Manufacturing and Supply Agreement • October 11th, 2016 • Accelerated Pharma, Inc. • Pharmaceutical preparations
THIS CLINICAL MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”) is made effective as of the 26” day of August, 2015 (“Effective Date”) by and between BAXTER ONCOLOGY GmbH, with an address at Kantstrasse 2, 33790 Halle/Westfalen, Germany, as such term is defined herein (“Baxter”), and ACCELERATED PHARMA, INC., a Delaware corporation having offices at 15W155 81’ Street, Burr Ridge, Illinois 60527 (“Client”).
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. CLINICAL MANUFACTURING AND SUPPLY AGREEMENTClinical Manufacturing and Supply Agreement • August 6th, 2014 • Ophthotech Corp. • Pharmaceutical preparations • New York
This Clinical Manufacturing and Supply Agreement (this “Agreement”) is entered into by and between AGILENT TECHNOLOGIES, INC., a Delaware corporation, having a principal office at 5301 Stevens Creek Blvd., Santa Clara, CA 95051 (“Agilent”) and OPHTHOTECH CORPORATION, a Delaware corporation, having a principal office at One Penn Plaza, Suite 1924, New York, NY 10119 (“Customer”) effective as of May 2, 2014 (the “Effective Date”). Agilent and Customer are each referred to herein as a “Party” and together as the “Parties”.
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. AMENDMENT NO. 1 TO THE CLINICAL MANUFACTURING AND SUPPLY AGREEMENT BY AND BETWEEN AGILENT TECHNOLOGIES, INC. AND...Clinical Manufacturing and Supply Agreement • November 5th, 2015 • Ophthotech Corp. • Pharmaceutical preparations
This Amendment No. 1 (this “Amendment”) amends the Clinical Manufacturing and Supply Agreement (the “Agreement”) by and between Agilent Technologies, Inc. (“Agilent”) and Ophthotech Corporation (“Customer”) dated May 2, 2014 (“Effective Date”).
